Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bryan Brewer

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of Lipid Research|February 11, 2003
Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrationsFederica Basso, Lita Freeman, Catherine L Knapper, et al.
Journal of Lipid Research|October 25, 2006
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibitedFederica Basso, Lita A Freeman, Carol Ko, et al.
The Journal of Biological Chemistry|March 27, 2004
Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic miceJustina E Wu, Federica Basso, Robert D Shamburek, et al.
The Journal of Biological Chemistry|January 30, 2004
The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier diseaseEdward B Neufeld, John A Stonik, Stephen J Demosky, et al.
Journal of the American College of Cardiology|June 12, 2010
A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndromeRon Waksman, Rebecca Torguson, Kenneth M Kent, et al.
Journal of Lipid Research|February 4, 2003
Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathwayAlan T Remaley, Fairwell Thomas, John A Stonik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout miceCharles W Joyce, Marcelo J A Amar, Gilles Lambert, et al.
Nature Reviews. Cardiology|August 11, 2017
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biologyRobert S Rosenson, H Bryan Brewer, Philip J Barter, et al.
Journal of Lipid Research|January 16, 2009
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivoFrank M Sacks, Lawrence L Rudel, Adam Conner, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 20, 2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialStephen J Nicholls, Rishi Puri, Kathy Wolski, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Lipid Research|February 11, 2003
Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrationsFederica Basso, Lita Freeman, Catherine L Knapper, et al.
Journal of Lipid Research|October 25, 2006
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibitedFederica Basso, Lita A Freeman, Carol Ko, et al.
The Journal of Biological Chemistry|March 27, 2004
Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic miceJustina E Wu, Federica Basso, Robert D Shamburek, et al.
The Journal of Biological Chemistry|January 30, 2004
The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier diseaseEdward B Neufeld, John A Stonik, Stephen J Demosky, et al.
Journal of the American College of Cardiology|June 12, 2010
A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndromeRon Waksman, Rebecca Torguson, Kenneth M Kent, et al.
Journal of Lipid Research|February 4, 2003
Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathwayAlan T Remaley, Fairwell Thomas, John A Stonik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout miceCharles W Joyce, Marcelo J A Amar, Gilles Lambert, et al.
Nature Reviews. Cardiology|August 11, 2017
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biologyRobert S Rosenson, H Bryan Brewer, Philip J Barter, et al.
Journal of Lipid Research|January 16, 2009
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivoFrank M Sacks, Lawrence L Rudel, Adam Conner, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 20, 2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialStephen J Nicholls, Rishi Puri, Kathy Wolski, et al.
Pageof 8